- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin: An Emerging Treatment for Alzheimer’s Disease Dementia?
Authors
Keywords
-
Journal
Current Neurology and Neuroscience Reports
Volume 12, Issue 5, Pages 520-527
Publisher
Springer Nature
Online
2012-07-13
DOI
10.1007/s11910-012-0297-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of Insulin and Octreotide on Memory and Growth Hormone in Alzheimer's Disease
- (2017) G. Stennis Watson et al. JOURNAL OF ALZHEIMERS DISEASE
- A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease
- (2017) Sofia Tzimopoulou et al. JOURNAL OF ALZHEIMERS DISEASE
- -Amyloid burden in healthy aging: Regional distribution and cognitive consequences
- (2012) K. M. Rodrigue et al. NEUROLOGY
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
- (2011) Jeffrey M. Burns et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
- (2011) C. Harrington et al. Current Alzheimer Research
- Type 2 Diabetes and Late-Onset Alzheimer’s Disease
- (2011) D. Cheng et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Insulin Reduces Neuronal Excitability by Turning on GABAA Channels that Generate Tonic Current
- (2011) Zhe Jin et al. PLoS One
- GSK3 and Alzheimer’s disease: facts and fiction…
- (2011) Anna Kremer Frontiers in Molecular Neuroscience
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) Michael Gold et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
- (2010) A. M. Abbatecola et al. DIABETES CARE
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
- (2009) Louis A. Profenno et al. BIOLOGICAL PSYCHIATRY
- Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia
- (2009) Baljinder Kaur et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
- (2009) Beatrice Scazzocchio et al. JOURNAL OF LIPID RESEARCH
- Human APOE Isoform-Dependent Effects on Brain -Amyloid Levels in PDAPP Transgenic Mice
- (2009) K. R. Bales et al. JOURNAL OF NEUROSCIENCE
- PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
- (2009) Haruo Hanyu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid
- (2009) Han-Kyu Lee et al. MOLECULAR BIOLOGY OF THE CELL
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease
- (2009) C. Sanz et al. NEUROLOGY
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease
- (2008) Pramod Kumar et al. BEHAVIOURAL BRAIN RESEARCH
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
- (2008) Leah R Hanson et al. BMC NEUROSCIENCE
- Mid- and Late-Life Diabetes in Relation to the Risk of Dementia: A Population-Based Twin Study
- (2008) W. Xu et al. DIABETES
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
- Impaired insulin secretion increases the risk of Alzheimer disease
- (2008) E. Ronnemaa et al. NEUROLOGY
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- Amyloid beta oligomers induce impairment of neuronal insulin receptors
- (2007) Wei-Qin Zhao et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started